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Background: Liposarcoma is one of the most common soft tissue sarcomas found in adults. It has a predilection
for retroperitoneal space. Renal cell carcinoma is the most common tumor of the kidney.
Case presentation: Concurrent retroperitoneal liposarcoma and renal cell carcinoma were found in a 34-year-old
Japanese man. The renal tumor was first detected by ultrasonography, it was confirmed by computed tomography,
which also identified a presumptive retroperitoneal liposarcoma, and the tumors were further assessed with magnetic
resonance imaging. The patient was treated by surgical resection of retroperitoneal liposarcoma and left nephrectomy
and has been disease-free for 10 years.
Conclusions: The concomitant occurrence of a renal tumor and a primary primary liposarcoma is rare. The major
factors promoting a good prognosis in this case were the favorable histology and the small size of the tumors.
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Liposarcoma is one of the most common soft tissue sar-
comas found in adults, and it usually occurs in the retro-
peritoneum and the extremities [1]. Its incidence rate
increases in middle-aged and older adults with a peak in
70–80 year olds. Renal cell carcinoma (RCC) is the most
common tumor of the kidney. Its incidence is highest in
those aged 50–70 years. The co-occurence of RCC and
hematological malignancies as well as solid tumors has
been reported.Case presentation
A 34-year-old Japanese man, with no significant previous
medical history, presented to our hospital because of
an incidentally detected renal tumor. The patient did
not have a family history of RCC or any signs of heredi-
tary RCC syndrome on examination. He did not have any
physical and laboratory findings indicating RCC including* Correspondence: vbilim@niigata-cc.jp
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unless otherwise stated.microscopic hematuria. Contrast enhanced computed
tomography (CT) (Figure 1A) confirmed a 2.5 cm left kid-
ney tumor; it showed the early enhancement and washout
typical of a clear cell RCC. Additionally, a retroperitoneal
tumor with calcification was identified, the presence of
lipid and soft tissue components was confirmed, and a
presumptive diagnosis of retroperitoneal liposarcoma was
made (Figure 1A). Abdominal magnetic resonance im-
aging (MRI) (Figure 1B, C) showed a tumor located in the
interaortocaval space with high signal intensity on the T2-
weighted images. No apparent metastases were identified.
Left partial nephrectomy and resection of the retroperi-
toneal tumor were performed in September 2003. The
pathological diagnoses were clear cell renal carcinoma and
retroperitoneal liposarcoma (Figure 2). The excised retro-
peritoneal tumor was a 6.8 × 4.8 cm well-circumscribed
mass. Cut sections of the tumor had a lobulated yellowish
appearance. Histological examination revealed the tumor
to be composed of a mixture of fibrous tissue and mature-
appearing adipose tissues (Figure 2C), with the fibrous tis-
sue separation the adipose tissue into regions of varied size.
The adipose cells appeared almost mature, but the tumortd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Comuted tomography (CT) and magnetic resonance
imaging (MRI) of the tumors. Left lower pole renal tumor (indicated
by arrows) and 5x4x7.5 cm interaortocaval tumor containing fatty tissue,
calcification and soft tissue components (indicated by filled arrowheads).
The inferior vena cava is compressed by the ineraortocaval tumor
(indicated by open arrowhead). (A) Contrast-enhanced CT, parenchymal
phase. Wash-out of the contrast is typical for clear cell RCC. Coronal
(B) and axial (C) contrast-enhanced MRI.
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cluding a few mono- or mutli-vacuolated lipoblastic cells.
The fibrous tissues contained muscle fibers. Few cells
were positive for MIB-1 antibody (proliferating cells).
The resected renal tumor was 1.6 × 1.6 cm in size,
histopathology showed a clear cell RCC (Figure 2D) cir-
cumscribed by a fibrous capsule, classified as G1 pT1a
(i.e. less than 4 cm in size and confined to the kidney).
Surgical margins of both tumors were negative and no ad-
juvant treatment was performed. Ten years after the oper-
ation, the patient is doing well and has not experienced a
recurrence.
Young patient age can indicate a hereditary RCC syn-
drome. However, our patient had no family history and
clinical signs of tuberous sclerosis, von Hippel-Lindau
disease, and succinate dehydrogenase-associated familial
cancer.
We identified five reported cases of concurrent lipo-
sarcoma and RCC [2-6] (Table 1). Patients age ranged
from 58 to 79 years (median 71 years), slightly older than
the average age for all RCC patients. The RCC histological
subtype was clear cell in 1 case [4], papillary cell in 3 cases
[2,3,6] and granular cell in 1 case [5] (note: it has recently
been shown that “granular cell” type RCC is not an inde-
pendent histological type). The location of liposarcoma
was perirenal [4,5] in 2 cases, retroperitoneal [2,6] in 2
cases, and cardiac [3] in 1 case (found by autopsy). Al-
though the number of reported cases is small, it is inter-
esting to note that only one case represented the clear cell
subtype whereas three cases were diagnosed as papillary
cell RCC. In the present case retroperitoneal liposarcoma
was located in interaortocaval space and RCC histology
was clear cell. Our case and all of the previously reported
cases were males, which fits with the male predisposition
for RCC.
In addition to the previously described cases, we found
two published case reports regarding liposarcomatous
differentiation in chromophobe RCCs [7,8]. In contrast,
the renal tumor in our case was a typical clear cell RCC,
and the two tumors represented distinct entities.
Over the last 15 years, 1123 patients with retroperiton-
eal soft tissue sarcoma have been reported in 25 series;
these tumors had a mean diameter of 15.7 cm [9]. Retro-
peritoneal soft tissue sarcomas represent 0.10 to 0.15%
of all malignancies and 45% of all retroperitoneal tu-
mors. Because of the localization, symptoms are nonspe-
cific (e.g., abdominal discomfort and palpable mass) and
caused by tumor growth, which is typically very large
when detected. The only curative treatment modality is
complete surgical resection; chemotherapy and radiation
therapy show no survival benefit. It has been reported
that 51.4% of these tumors can be completely excised
and that 50.2% of these excisions include adjacent or-
gans [9]. The prognosis without complete excision is
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Figure 2 Macro- and microphotograph of the resected tumors. Resected retroperitoneal tumor (A) and kidney tumor (B). Microphotograph
of hematoxylin & eosin stained tissue section of the retroperitoneal tumor (C) represents the picture of a typical well-differentiated liposarcoma
(X40). Microphotograph of hematoxylin & eosin stained tissue section of kidney tumor (D) represents clear cell RCC (X40).
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and 8.0% respectively [9].
Local recurrence represents the major type of progres-
sion for retroperitoneal liposarcomas. Yamamoto et al.
[10] described 45 patients with well-differentiated lipo-
sarcoma who underwent surgical treatment. Among 41
patients who underwent initial surgery, only one recur-
rence occurred, which was localized in the retroperiton-








[2] 2013 74 Papillary 1.1 × 1.1 × 0.4 cm Left
[3] 2003 58 Papillary 1.0 cm Left









Abbreviations: NA not applicable, NED no evidence of disease, RCC renal cell carcinothe mean time between the initial surgery and the recur-
rence was 16.5 years. None of the 45 patients developed
distant metastasis. In our case, during the 10 years of
follow-up to date, no recurrence or metastasis has been
detected. However, continued follow-up is necessary be-
cause late recurrences are common with liposarcoma.
Previously reported liposarcomas have demonstrated
heterogeneous signal intensity on MRI with great variation
depending on the components and histological patterns ofosarcoma associated with renal cell carcinoma (RCC)
Liposarcoma location Liposarcomasize Recurrence




Perirenal 7.6 × 5.0 cm NED 24 months
Perirenal No data 17 months no recurrence
Retroperitoneum (invasion
of the proximal ureter)
40 cm, 20 cm
and 14 cm
Recurrent liposarcoma, no
data on follow up
ma.
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classified into several clinico-pathological subtypes [11].
Myxoid liposarcoma, consisting of a myxoid matrix and
a small amount of mature fat, shows low signal intensity
on T1 weighted image and high signal intensity on T2
weighted image [11]. Well-differentiated liposarcoma
presented high signal intensity on T1 weighted im-
ages, intermediate signal intensity on T2 weighted im-
ages, drop-out signal intensity on fat-suppressed MR
images [11]. Round-cell liposarcoma and pleomorphic
liposarcoma exhibit the signal intensity of a soft-tissue
tumor without a characteristic fat signal [11]. Liposarco-
mas can present with intratumoral hemorrhage and may
invade adjacent organs. In the present case, the tumor
showed high signal intensity on the T2-weighted images,
which is typical for myxoid liposarcoma and is incon-
sistent with well-differentiated liposarcoma which was
diagnosed pathologically. Five-year and ten-year disease
specific survival is the highest for well-differentiated lipo-
sarcoma (100% and 87%) followed by myxoid liposar-
coma (88% and 76%), and is the lowest for pleomorphic
liposarcoma (56% and 39%) (http://sarcomahelp.org/
liposarcoma.html).
Conclusion
We have presented a case of concomitant RCC and retro-
peritoneal liposarcoma in a young male. Although no data
exists regarding an association between these two malig-
nant tumors, a genetic predisposition for cancer is likely
present given patient’s young age. Both tumors were com-
pletely surgically excised and no relapse has been seen
during ten-year follow-up to date. The major factors pro-
moting a good prognosis in this case were favorable hist-
ology and small size of the tumors at initial diagnosis.
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